Wanbury Limited (WANBURY) — Board Meeting | 11 August 2026

11 August 2026 · NSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Board approved Q1 FY2026 results and ESOP share allotment increasing paid-up capital.

🔮 What's Next

Re-appointment of Mr. Mohan Kumar Rayana as Whole-time Director effective August 21, 2026, pending shareholder approval.

💡 Investor Takeaway

The capital increase from ESOP exercises slightly dilutes existing shares but reflects employee confidence.

Wanbury Limited announced the outcome of its August 11, 2026 board meeting, approving unaudited Q1 FY2026 financial results and an employee stock option exercise that increases paid-up capital. The board also reappointed Mr. Mohan Kumar Rayana as Whole-time Director effective August 21, 2026, subject to shareholder approval. The filing includes disclosures under SEBI regulations regarding the ESOP allotment and director appointment.

📄 View Original Announcement (PDF)

📊 Stock Analysis — WANBURY ✨ Ask AI About This

About Wanbury Limited (WANBURY)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹758.71 CrP/E: 16.6ROE: 80.7%ROCE: 34.9%

View full WANBURY stock details →

📡 Get AI alerts when WANBURY files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track WANBURY — Free

💡 Ask AI about this filing

"How does the new paid-up capital affect existing shareholders' ownership percentage?""What is the expected impact of the director reappointment on company strategy?""When will the revised diluted EPS be reflected in future quarterly reports?"

Ask AI Free →

📊 More WANBURY filings

Announcement — 29 September 2026Wanbury Ltd announced the closure of its insider trading window effective October 1, 2026, covering ...
🟡 Board Meeting — 24 September 2026Wanbury Limited announced at its 38th Annual General Meeting on September 24, 2026, the appointment ...
🟡 Board Meeting — 24 September 2026Wanbury Ltd held its 38th AGM on September 24, 2026, approving audited FY2026 financials, reappointi...
🟡 Board Meeting — 31 August 2026Wanbury Ltd announced that its 38th Annual General Meeting will be held on 24 September 2026 via vid...
🔴 Annual Report — 31 August 2026Wanbury Ltd's 2025-26 Annual Report shows revenue of ₹65,120.54 lakhs and net profit of ₹6,613.47 la...

See all WANBURY filings →

🔥 Also filed on 11 August 2026

ULTRACEMCOUltraTech Cement LimitedAnnouncement SUDEEPPHRMSudeep Pharma LimitedFinancial Results SUTLEJTEXSutlej Textiles and Industries LimitedFinancial Results RBZJEWELRBZ Jewellers LimitedFinancial Results TATVATatva Chintan Pharma Chem LimitedCorporate Action AETHERAether Industries LimitedCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when WANBURY files new disclosures

Track WANBURY filings, board meetings, and corporate actions. Free email alerts at 5 PM.